NCT05800210: Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Acute Lymphoblastic Leukemia
This Phase 2 study is evaluating Miltenyi CliniMACS Prodigy system for Acute Lymphoblastic Leukemia.
This Phase 2 study is evaluating Miltenyi CliniMACS Prodigy system for Acute Lymphoblastic Leukemia.
Evidence level: Sejtvonalas. Laboratóriumi sejtekben vizsgálták.
Related signals
- Acute Myeloid Leukemia Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf
- Recent advances on blinatumomab for acute lymphoblastic leukemia
- Advancing the Diagnosis of Non‑Hodgkin Lymphoma Through Next‑Generation Sequencing in Developing Countries: An Evaluation of Progress — A Narrative Review
- The Evolving Therapeutic Revolution in Adult Acute Lymphoblastic Leukemia
- Childhood Acute Lymphoblastic Leukemia Treatment (PDQ®)